Supplemental testing methods - PowerPoint PPT Presentation

slide1 n.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
Supplemental testing methods PowerPoint Presentation
Download Presentation
Supplemental testing methods

play fullscreen
1 / 21
Supplemental testing methods
183 Views
Download Presentation
jaeger
Download Presentation

Supplemental testing methods

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. Supplemental testing methods Screening agar Agar contains known conc. of antibiotic Growth on agar indicates resistance Oxacillin screening agar: 6 g/ml oxacillin Screening of staphylococci Vancomycin screening agar: 6 g/ml vanco Screening of enterococci and staphylococci

  2. Supplemental testing methods Predictor drugs Staphylococci R to Oxacillin = R to penicillins, cephalosporins, and imipenem High level gentimicin R in enterococci = R to all currently available aminoglycosides Ampicillin R in enterococci = R to all penicillin derivatives and imipenem

  3. Direct detection of resistance mechanisms Beta-lactamase (phenotypic) Chromogenic substrate incorporated into disk - color change in presence of enzyme Usefulness is limited: Penicillin R in Neisseria gonorrhea Ampicillin R in Haemophilus influenzae Penicillin R in anaerobes

  4. Direct detection of resistance mechanisms Extended spectrum beta-lactamase Mutations in plasmid-encoded beta-lactamases - hydrolyze extended spectrum cephalosporins and aztreonam - more than 100 types have been identified - isolates are often resistant to other classes Interpretive criteria available for: - E. coli, K. pneumoniae, K. oxytoca, P. mirabilis

  5. Direct detection of resistance mechanisms Extended spectrum beta-lactamase Screen with aztreonam or cefpodoxime R = requires confirmatory testing Confirmatory testing: Ceftazidime v. ceftaz + clavulanic acid Cefotaxime v. cefotax + clavulanic acid KB: >/= 5 mm increase w/ BLI MIC: >/= 3-fold decr in MIC w/ BLI

  6. With clavulanic acid Without clavulanic acid

  7. Direct detection of resistance mechanisms Oxacillin R due to PBP2a (phenotypic) Latex agglutination test to detect altered PBP in staphylococci Presence confers resistance to Oxacillin Depends on expression of protein

  8. Direct detection of resistance mechanisms Oxacillin R due to PBP2a (genotypic) PCR to detect mecA gene in staphylococci Positive not dependent on expression, a positive result simply indicates presence

  9. Direct detection of resistance mechanisms Inducible clindamycin resistance (D test) Resistance to macrolides can occur through: efflux (msrA) ribosome alteration (erm) Erythro R msrA or inducible erm Clinda S Erythro R constitutive erm Clinda R

  10. L: Erythro, R: Clinda No resistance Efflux Constitutive erm Inducible erm

  11. Laboratory strategies for testing Goals of effective strategies include: Relevance Accuracy Communication

  12. Laboratory strategies for testing Criteria used for assessing relevance: Clinical significance of isolate Predictability of susceptibility against drugs of choice Availability of reliable standardized methods Selection of appropriate agents

  13. Laboratory strategies for testing Clinical significance Abundance in direct smear Ability to cause disease in that body site Colonizer or pathogen? Body site of isolation

  14. Laboratory strategies for testing Predictability of susceptibility Testing not required when susceptibility is predictable Pen S in beta-hemolytic streptococci Ceph S in GC Clinical requirements can result in exceptions

  15. Laboratory strategies for testing Availability of standardized methods Testing cannot be performed if standardized method does not exist Method and interpretive guidelines required – CLSI guide Info available for most pathogenic bacteria Fungi, Nocardia, AFB (Mycobacterium)

  16. Laboratory strategies for testing Selection of agents Previously discussed criteria: Organism ID or group Acquired resistance patterns Testing method used Site of infection Formulary

  17. Laboratory strategies for testing Communication Prompt and thorough review of results Prompt resolution of unusual results Augment susceptibility reports with messages that help clarify and explain potential therapeutic problems not necessarily evident by data alone

  18. Antibiograms: The hospital antibiogram is a periodic summary of antimicrobial susceptibilities of local bacterial isolates submitted to the hospital's clinical microbiology laboratory. Antibiograms are often used by clinicians to assess local susceptibility rates, as an aid in selecting empiric antibiotic therapy, and in monitoring resistance trends over time within an institution.

  19. Antibiograms: Antibiograms can also used to compare susceptibility rates across institutions and track resistance trends. These trends can then be used to develop the appropriate formulary for the hospital.